Company news

Ocumension Therapeutics news in 2024

Ocumension Therapeutics's news releases, calls and decks from 2024, newest first.

View company

OcuMension acquires rights to Alcon eye drops in exchange for a 16.7% equity stake, signaling the commencement of comprehensive strategic relationship

August 12, 2024

OcuMension (01477.HK) Invests Over RMB 123.8 Million in Research, Technology and Self-development Progress in Tandem, Main Product Sales Show Comprehensive Growth

March 21, 2024